Adeshwar Meditex Ltd
Incorporated in 2007, Adeshwar Meditex Ltd is a manufacturer and exporter of all forms of first aid kits, surgical dressing, surgical plastics and other medical disposables[1]
- Market Cap ₹ 34.0 Cr.
- Current Price ₹ 23.6
- High / Low ₹ 36.0 / 20.0
- Stock P/E 15.6
- Book Value ₹ 24.8
- Dividend Yield 0.00 %
- ROCE 9.62 %
- ROE 5.93 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.95 times its book value
- Promoter holding has increased by 14.9% over last quarter.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 8.58% over past five years.
- Company has a low return on equity of 5.32% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 58.60 | 52.92 | 56.12 | 65.97 | 64.76 | 82.36 | 79.85 | 74.49 | |
| 52.96 | 47.44 | 50.64 | 61.22 | 61.39 | 77.14 | 74.66 | 69.51 | |
| Operating Profit | 5.64 | 5.48 | 5.48 | 4.75 | 3.37 | 5.22 | 5.19 | 4.98 |
| OPM % | 9.62% | 10.36% | 9.76% | 7.20% | 5.20% | 6.34% | 6.50% | 6.69% |
| 0.10 | 0.25 | 0.28 | 0.13 | 0.23 | 0.31 | 0.13 | 0.26 | |
| Interest | 1.78 | 2.23 | 2.52 | 2.19 | 2.03 | 2.09 | 1.93 | 1.61 |
| Depreciation | 0.36 | 0.35 | 0.34 | 0.35 | 0.38 | 0.53 | 0.60 | 0.56 |
| Profit before tax | 3.60 | 3.15 | 2.90 | 2.34 | 1.19 | 2.91 | 2.79 | 3.07 |
| Tax % | 29.72% | 28.25% | 27.24% | 28.63% | 33.61% | 28.52% | 27.96% | |
| 2.54 | 2.26 | 2.12 | 1.68 | 0.79 | 2.07 | 2.01 | 2.18 | |
| EPS in Rs | 5.10 | 4.54 | 4.03 | 1.60 | 0.55 | 1.43 | 1.39 | 1.51 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 7% |
| TTM: | -10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -2% |
| 3 Years: | 4% |
| TTM: | 27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -10% |
| 1 Year: | -6% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | 5% |
| Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.98 | 4.98 | 5.27 | 10.53 | 14.43 | 14.43 | 14.43 | 14.43 |
| Reserves | 8.55 | 10.81 | 13.64 | 10.05 | 16.52 | 18.48 | 20.48 | 21.38 |
| 11.58 | 19.92 | 21.32 | 22.45 | 18.99 | 16.43 | 13.89 | 12.08 | |
| 7.33 | 5.79 | 14.57 | 19.27 | 22.63 | 17.67 | 15.23 | 16.68 | |
| Total Liabilities | 32.44 | 41.50 | 54.80 | 62.30 | 72.57 | 67.01 | 64.03 | 64.57 |
| 2.36 | 2.44 | 2.28 | 2.24 | 3.03 | 3.70 | 3.53 | 3.20 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.02 | 0.04 | 0.08 | 0.08 | 0.10 | 0.10 | 0.10 | 0.00 |
| 30.06 | 39.02 | 52.44 | 59.98 | 69.44 | 63.21 | 60.40 | 61.37 | |
| Total Assets | 32.44 | 41.50 | 54.80 | 62.30 | 72.57 | 67.01 | 64.03 | 64.57 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| -0.99 | 3.15 | -2.44 | 5.77 | 3.84 | |||
| 1.58 | -0.71 | -1.16 | -1.16 | -0.22 | |||
| -0.07 | -3.11 | 4.44 | -4.63 | -4.36 | |||
| Net Cash Flow | 0.53 | -0.66 | 0.85 | -0.02 | -0.75 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 108.69 | 134.63 | 181.26 | 150.82 | 183.06 | 123.78 | 115.51 |
| Inventory Days | 64.44 | 112.51 | 119.36 | 174.35 | 168.24 | 127.72 | 138.71 |
| Days Payable | 43.11 | 38.76 | 104.70 | 119.86 | 138.51 | 88.18 | 75.97 |
| Cash Conversion Cycle | 130.02 | 208.39 | 195.93 | 205.31 | 212.79 | 163.33 | 178.25 |
| Working Capital Days | 129.43 | 211.19 | 222.82 | 194.70 | 221.28 | 179.13 | 187.69 |
| ROCE % | 17.69% | 14.27% | 11.22% | 6.93% | 10.07% | 9.62% |
Documents
Announcements
-
Non-Applicability Of RPT Under Reg 23 Of SEBI(LODR) Regulation, 2015
13 Nov - Non-applicability of Related Party Transactions for half year.
-
Outcome Of Board Meeting Held On Wednesday, November 13, 2024 For Approval Of Unaudited Financial Results For Half Year Ended September 30, 2024
13 Nov - Board meeting outcome and unaudited financial results.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, November 13, 2024 For Approval Of Unaudited Financial Results For Half Year Ended September 30, 2024
13 Nov - Board meeting outcome and unaudited financial results.
-
Board Meeting Intimation for Intimation Of 03Rd Board Meeting To Be Held On November 13, 2024 At Its Registered Office At 12.30 PM (IST)
8 Nov - Board meeting to approve financial results on Nov 13, 2024.
-
Half -Yearly Compliances-Statement Of Deviation(S) Or Variation(S).
16 Oct - Half-yearly compliance statement with no deviations.
Business Overview:[1][2]
Company is a WHO cGMP, CE, ISO 9001-2008 Certified manufacturer and exporter of sterile surgical wound dressing products and medical disposables. It deals in all kinds of surgical, pharmaceutical, medicine items including first aid kits, surgical dressings including sterile medicated wound dressings, sterile advanced hemostatic dressings, chitosan, oxidized cellulose and gelatin sponges, medical bandages, medical kits, Home Based New Born (HBNC) and other kits, face masks, and dealing in various items and Turnkey projects for all of the above products and other ancillary business